%0 Journal Article
%T Standard set of patient-reported outcomes for personality disorder.
%A Prevolnik Rupel V
%A Jagger B
%A Fialho LS
%A Chadderton LM
%A Gintner T
%A Arntz A
%A Baltzersen ÅL
%A Blazdell J
%A van Busschbach J
%A Cencelli M
%A Chanen A
%A Delvaux C
%A van Gorp F
%A Langford L
%A McKenna B
%A Moran P
%A Pacheco K
%A Sharp C
%A Wang W
%A Wright K
%A Crawford MJ
%J Qual Life Res
%V 30
%N 12
%D Dec 2021
%M 34075531
%F 3.44
%R 10.1007/s11136-021-02870-w
%X OBJECTIVE: The purpose of the article is to present standard set of outcomes for people with personality disorder (PD), in order to facilitate patient outcome measurement worldwide.
METHODS: The International Consortium for Health Outcomes Measurement (ICHOM) gathered a multidisciplinary international working group, consisting of 16 experts, including clinicians, nurses, psychologists, methodologists and patient representatives, to develop a standard set of outcome measures for people with PD. The Delphi method was used to reach consensus on the scope of the set, outcome domains, outcome measures, case-mix variables and time points for measuring outcomes in service users. For each phase, a project team prepared materials based on systematic literature reviews and consultations with experts.
RESULTS: The working group decided to include PD, as defined by International Classification of Diseases 11th revision (ICD-11). Eleven core outcomes and three optional outcomes across four health domains (mental health, behaviour, functioning and recovery) were defined as those relevant for people with PD. Validated measures for the selected outcomes were selected, some covering more than one outcome. Case-mix variables were aligned to other ICHOM mental health standard sets and consisted of demographic factors and those related to the treatment that people received. The group recommended that most outcomes are measured at baseline and annually.
CONCLUSIONS: The international minimum standard set of outcomes has the potential to improve clinical decision making through systematic measurement and comparability. This will be key in improving the standard of health care for people with PD across the world.